Authors

Updated Clinical Guidelines Outline Optimal Treatment of Helicobacter pylori Infection

For pharmacists wondering whether bismuth quadruple therapy still reigns as the gold standard, the wait is over—the latest recommendations are here.

Managing Sustainable Drug Spend: 5 Trends Reshaping Pharmacy Benefits in 2025

The US health care market faces transformative changes in 2025, as biosimilars, GLP-1s, and new pharmacy economics reshape how benefit managers balance innovation with affordability.

Comparative Oncology: Advances in Cancer Care from Pets to Humans

Dogs share a number of cancers with humans, including melanoma, non-Hodgkin lymphoma, leukemia, and osteosarcoma.

Stronger Criteria, Weaker Evidence: Evaluating STOPP/START Version 3 for Geriatric Care

New research reveals weaknesses in the STOPP/START version 3 criteria, highlighting the need for stronger evidence in geriatric medication management.

Research Underscores the Critical Role of Pharmacists in Managing Stiff Person Syndrome

Stiff Person Syndrome has unique complexities, necessitating the role of pharmacists in managing its symptoms and treatment options.

Pharmacy Deserts: A Crisis Health Care Providers Can Help Solve with Technology and Teamwork

Strategic AI Budgeting for Pharmacies in 2025

Pharmacies can strategically invest in AI technologies to streamline operations and improve patient care while addressing cost challenges and maximizing return on investment in 2025.

Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season

Lessons from the past season could strengthen prevention and drive vaccinations for 2025-2026.

The SUGAR Handshake Could Be a Sweet Option for Safer Diabetes Care

Researchers unveil a pharmacist-led intervention to enhance hypoglycemia management in older adults with type 2 diabetes, improving patient outcomes.

Personalized Prevention: Identifying At-Risk Patients With Image-Based Screening

Anna Sophie Mueller, MD discusses how imaging could advance risk identification in cardiovascular care.

Emerging Bispecific T-Cell Engagers in Myeloma: Promises and Hurdles

The multiple myeloma landscape is evolving, with bispecific T-cell engagers offering hope.

Beyond Injections: Orforglipron and the Future of Oral GLP-1 Receptor Agonist Therapy

New Walgreens Program Aims to Enable Pharmacy Technicians to Pursue PharmD Degrees

PharmStart empowers pharmacy technicians to pursue their education with tuition-free prerequisites, addressing barriers to entering pharmacy school.

Opinion: Pharmacists Are Critical to Ensure Safe, Ethical Integration of AI in Health Care

Pharmacists’ expertise is vital to AI’s safe integration into medication management. A growing array of resources and training supports pharmacists’ engagement with this new technology.

Gold Bagging: Setting the Gold Standard for Patients

Gold bagging integrates health system-owned specialty pharmacies with clinical workflows to enhance safety, efficiency, outcomes, and patient experience.

Circulating Tumor DNA (ctDNA) Testing to Predict Response in Solid Tumors

ctDNA analysis revolutionizes cancer treatment by predicting responses, detecting resistance, and monitoring minimal residual disease in patients.

Pharmacists Improve Lipid Control in Underserved Settings

Integrating a pharmacist into multidisciplinary settings allowed for more thorough low-density lipoprotein cholesterol lowering in unique settings.

Guiding Patients Through Allergy Medication Safety: Pharmacists’ Role Following FDA Warning on Cetirizine and Levocetirizine

The FDA is warning of rare severe itching after stopping long-term use of popular allergy medications cetirizine and levocetirizine, urging patient education.

Dry Mouth: Its Etiology, Symptoms, and Strategies for Management

Pharmacists with a deeper knowledge of xerostomia are ideally positioned to help educate patients with dry mouth on making informed self-care decisions for effective symptom management and improved quality of life.

An Overview of Vitamins and Supplements in Multiple Sclerosis

By examining the evidence, pharmacists can gain insights into whether these supplements could be integrated into MS treatment regimens to improve patient outcomes.

Clearing the Air: The Influence of Vaping on Smoking Cessation

Pharmacists can help address nicotine addiction by recommending FDA-approved smoking cessation methods and educating on the risks associated with electronic cigarette use.

McKesson ideaShare 2025: Micro-Access Pharmacies Expand Care Through Innovation, Technology, and Policy

Examining an Important Orphan Disease: Neurotrophic Keratitis/Keratopathy and Its Treatment

NK is a degenerative corneal disease resulting from diminished corneal innervation.

A Hospital’s Outpatient Pharmacies Attempt to Reduce DIR Fees Using Performance Reports

This quality improvement initiative demonstrates that pharmacies were unable to use performance reports provided by the payer to improve performance scores and decrease direct and indirect remuneration (DIR) fees.

DPYD Testing Gains Ground: NCCN Guideline Update Reflects Decades of Work Toward Safer Chemotherapy

The Phase 3 AMPLIFY Trial Assesses a New Treatment Paradigm in Patients With Treatment-Naive CLL

Investigators assessed fixed-duration venetoclax plus acalabrutinib with or without obinutuzumab vs chemoimmunotherapy.

Unlocking PROTACs’ Potential: Overcoming Development Challenges

Proteolysis-targeting chimeras hold enormous potential, but also present significant challenges to drug developers.

Paradoxical Hypotension After Inadvertent Intravenous Administration of Epinephrine

Raising awareness of the potentially fatal cardiovascular complications of epinephrine toxicity.

Omalizumab: An All-in-One Allergy Wonder Drug?

Omalizumab expands its role in allergy management, now FDA-approved for food allergies, showcasing potential for broader applications in allergic rhinitis.